26.71BMarket Cap-81515P/E (TTM)
32.250High29.300Low7.20MVolume31.900Open31.350Pre Close223.15MTurnover0.83%Turnover Ratio33.90P/E (Static)871.47MShares35.90052wk High4.62P/B26.71BFloat Cap19.00052wk Low--Dividend TTM871.47MShs Float85.800Historical High--Dividend LFY9.41%Amplitude11.360Historical Low30.996Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
HUTCHMED Stock Forum
$Hutchmed (China) (HCM.US)$
$Intra-Cellular Therapies (ITCI.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$Hutchmed (China) (HCM.US)$ Phase 3
$Viracta Therapeutics (VIRX.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Marinus Pharmaceuticals (MRNS.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3 ...
According to the ac...
No comment yet